Literature DB >> 32035060

mTORC2 Signaling Is Necessary for Timely Liver Regeneration after Partial Hepatectomy.

Meng Xu1, Haichuan Wang2, Jingxiao Wang3, Deviana Burhan4, Runze Shang5, Pan Wang6, Yi Zhou7, Rong Li8, Bingyong Liang9, Katja Evert10, Kirsten Utpatel10, Zhong Xu11, Xinhua Song12, Li Che12, Diego F Calvisi10, Bruce Wang4, Xi Chen13, Yong Zeng14, Xin Chen15.   

Abstract

Liver regeneration is a fundamental biological process required for sustaining body homeostasis and restoring liver function after injury. Emerging evidence demonstrates that cytokines, growth factors, and multiple signaling pathways contribute to liver regeneration. Mammalian target of rapamycin complex 2 (mTORC2) regulates cell metabolism, proliferation and survival. The major substrates for mTORC2 are the AGC family members of kinases, including AKT, SGK, and PKC-α. We investigated the functional roles of mTORC2 during liver regeneration. Partial hepatectomy (PHx) was performed in liver-specific Rictor (the pivotal unit of mTORC2 complex) knockout (RictorLKO) and wild-type (Rictorfl/fl) mice. Rictor-deficient mice were found to be more intolerant to PHx and displayed higher mortality after PHx. Mechanistically, loss of Rictor resulted in decreased Akt phosphorylation, leading to a delay in hepatocyte proliferation and lipid droplets formation along liver regeneration. Overall, these results indicate an essential role of the mTORC2 signaling pathway during liver regeneration.
Copyright © 2020 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32035060      PMCID: PMC7180798          DOI: 10.1016/j.ajpath.2019.12.010

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

Review 1.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

2.  New concepts in liver regeneration.

Authors:  Kimberly J Riehle; Yock Y Dan; Jean S Campbell; Nelson Fausto
Journal:  J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 4.029

3.  Akt-mediated foxo1 inhibition is required for liver regeneration.

Authors:  Montse Pauta; Noemi Rotllan; Ana Fernández-Hernando; Cedric Langhi; Jordi Ribera; Mingjian Lu; Loreto Boix; Jordi Bruix; Wladimiro Jimenez; Yajaira Suárez; David A Ford; Angel Baldán; Morris J Birnbaum; Manuel Morales-Ruiz; Carlos Fernández-Hernando
Journal:  Hepatology       Date:  2015-12-18       Impact factor: 17.425

4.  Addendum: A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice.

Authors:  Claudia Mitchell; Holger Willenbring
Journal:  Nat Protoc       Date:  2014       Impact factor: 13.491

Review 5.  Hepatostat: Liver regeneration and normal liver tissue maintenance.

Authors:  George K Michalopoulos
Journal:  Hepatology       Date:  2017-03-06       Impact factor: 17.425

6.  The variation of AkT/TSC1-TSC1/mTOR signal pathway in hepatocytes after partial hepatectomy in rats.

Authors:  Ping Chen; Hongtao Yan; Yin Chen; Zhonglin He
Journal:  Exp Mol Pathol       Date:  2009-04       Impact factor: 3.362

7.  mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc.

Authors:  Kenta Masui; Kazuhiro Tanaka; David Akhavan; Ivan Babic; Beatrice Gini; Tomoo Matsutani; Akio Iwanami; Feng Liu; Genaro R Villa; Yuchao Gu; Carl Campos; Shaojun Zhu; Huijun Yang; William H Yong; Timothy F Cloughesy; Ingo K Mellinghoff; Webster K Cavenee; Reuben J Shaw; Paul S Mischel
Journal:  Cell Metab       Date:  2013-10-17       Impact factor: 27.287

8.  The survival pathways phosphatidylinositol-3 kinase (PI3-K)/phosphoinositide-dependent protein kinase 1 (PDK1)/Akt modulate liver regeneration through hepatocyte size rather than proliferation.

Authors:  Sanae Haga; Michitaka Ozaki; Hiroshi Inoue; Yasuo Okamoto; Wataru Ogawa; Kiyoshi Takeda; Shizuo Akira; Satoru Todo
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

9.  Impact of rapamycin on liver regeneration.

Authors:  Daniel Palmes; Andree Zibert; Tymotheus Budny; Ralf Bahde; Evgeny Minin; Linus Kebschull; Jens Hölzen; Hartmut Schmidt; Hans-Ullrich Spiegel
Journal:  Virchows Arch       Date:  2008-05       Impact factor: 4.064

10.  Self-renewing diploid Axin2(+) cells fuel homeostatic renewal of the liver.

Authors:  Bruce Wang; Ludan Zhao; Matt Fish; Catriona Y Logan; Roel Nusse
Journal:  Nature       Date:  2015-08-05       Impact factor: 49.962

View more
  4 in total

1.  Mesenchymal stem cells ameliorate lipid metabolism through reducing mitochondrial damage of hepatocytes in the treatment of post-hepatectomy liver failure.

Authors:  Jing-Lin Wang; Hao-Ran Ding; Chen-Yan Pan; Xiao-Lei Shi; Hao-Zhen Ren
Journal:  Cell Death Dis       Date:  2021-01-21       Impact factor: 8.469

2.  Liver-specific deletion of mechanistic target of rapamycin does not protect against acetaminophen-induced liver injury in mice.

Authors:  Hua Sun; Hong-Min Ni; Jennifer M McCracken; Jephte Y Akakpo; Sam Fulte; Tara McKeen; Hartmut Jaeschke; Hua Wang; Wen-Xing Ding
Journal:  Liver Res       Date:  2021-03-19

Review 3.  Macrophages, Chronic Inflammation, and Insulin Resistance.

Authors:  He Li; Ya Meng; Shuwang He; Xiaochuan Tan; Yujia Zhang; Xiuli Zhang; Lulu Wang; Wensheng Zheng
Journal:  Cells       Date:  2022-09-26       Impact factor: 7.666

4.  Verapamil induces autophagy to improve liver regeneration in non-alcoholic fatty liver mice.

Authors:  Jian-Lin Lai; Yuan-E Lian; Jun-Yi Wu; Yao-Dong Wang; Yan-Nan Bai
Journal:  Adipocyte       Date:  2021-12       Impact factor: 4.534

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.